[{"orgOrder":0,"company":"EG 427","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Urology","country":"FRANCE","productType":"Cell and Gene therapy","year":"2024","type":"Inapplicable","leadProduct":"EG110A","moa":"||Botulinum toxin fragment","graph1":"Urology","graph2":"Phase I\/ Phase II","graph3":"EG 427","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"Urology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"EG 427 \/ Inapplicable","highestDevelopmentStatusID":"7","companyTruncated":"EG 427 \/ Inapplicable"},{"orgOrder":0,"company":"Fraser Health","sponsor":"BC Support Unit | Michael Smith Foundation for Health Research","pharmaFlowCategory":"DU","therapeuticArea":"Urology","country":"","productType":"Other Small Molecule","year":"2020","type":"Inapplicable","leadProduct":"Tranexamic Acid","moa":"||Plasminogen","graph1":"Urology","graph2":"Phase I\/ Phase II","graph3":"Fraser Health","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"Urology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Fraser Health \/ BC Support Unit | Michael Smith Foundation for Health Research","highestDevelopmentStatusID":"7","companyTruncated":"Fraser Health \/ BC Support Unit | Michael Smith Foundation for Health Research"},{"orgOrder":0,"company":"University of Louisville","sponsor":"Integrative Therapeutics","pharmaFlowCategory":"DU","therapeuticArea":"Urology","country":"","productType":"Plant Extract\/Herbal","year":"2021","type":"Inapplicable","leadProduct":"Mentha Piperita Oil","moa":"||Smooth muscle","graph1":"Urology","graph2":"Phase I\/ Phase II","graph3":"University of Louisville","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"Urology","amount2New":0,"dosageForm":"Oil","sponsorNew":"University of Louisville \/ Integrative Therapeutics","highestDevelopmentStatusID":"7","companyTruncated":"University of Louisville \/ Integrative Therapeutics"},{"orgOrder":0,"company":"Holostem","sponsor":"Fondazione IRCCS Ca' Granda | University of Modena and Reggio Emilia","pharmaFlowCategory":"DU","therapeuticArea":"Urology","country":"","productType":"Cell and Gene therapy","year":"2021","type":"Inapplicable","leadProduct":"Autologous Human Oral Epithelium Stem Cell","moa":"||Undisclosed","graph1":"Urology","graph2":"Phase I\/ Phase II","graph3":"Holostem","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"Urology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Holostem \/ Fondazione IRCCS Ca' Granda | University of Modena and Reggio Emilia","highestDevelopmentStatusID":"7","companyTruncated":"Holostem \/ Fondazione IRCCS Ca' Granda | University of Modena and Reggio Emilia"},{"orgOrder":0,"company":"Hackensack Meridian Health","sponsor":"Inapplicable","pharmaFlowCategory":"DU","therapeuticArea":"Urology","country":"U.S.A","productType":"Other Small Molecule","year":"2022","type":"Inapplicable","leadProduct":"Tamsulosin","moa":"||Adrenergic receptor alpha-1","graph1":"Urology","graph2":"Phase I\/ Phase II","graph3":"Hackensack Meridian Health","amount2":0,"highestDevelopmentShortName":"Ph I\/II","therapeuticAreaShortName":"Urology","amount2New":0,"dosageForm":"Catheter","sponsorNew":"Hackensack Meridian Health \/ Inapplicable","highestDevelopmentStatusID":"7","companyTruncated":"Hackensack Meridian Health \/ Inapplicable"}]

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          EPSC
                          Not Confirmed
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Cell and Gene therapy

                          Upfront Cash : Inapplicable

                          September 19, 2024

                          Lead Product(s) : EG110A,Inapplicable

                          Therapeutic Area : Urology

                          Highest Development Status : Phase I/ Phase II

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          02

                          Holostem

                          Country arrow
                          EPSC
                          Not Confirmed

                          Holostem

                          Country arrow
                          EPSC
                          Not Confirmed

                          Lead Product(s) : Autologous Human Oral Epithelium Stem Cell,Inapplicable

                          Therapeutic Area : Urology

                          Study Phase : Phase I/ Phase II

                          Sponsor : Fondazione IRCCS Ca' Granda | University of Modena and Reggio Emilia

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Cell and Gene therapy

                          Upfront Cash : Inapplicable

                          October 26, 2021

                          Lead Product(s) : Autologous Human Oral Epithelium Stem Cell,Inapplicable

                          Therapeutic Area : Urology

                          Highest Development Status : Phase I/ Phase II

                          Sponsor : Fondazione IRCCS Ca' Granda | University of Modena and Reggio Emilia

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          University of Louisville

                          Country arrow
                          EPSC
                          Not Confirmed

                          University of Louisville

                          Country arrow
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Plant Extract/Herbal

                          Upfront Cash : Inapplicable

                          April 14, 2021

                          Lead Product(s) : Mentha Piperita Oil,Inapplicable

                          Therapeutic Area : Urology

                          Highest Development Status : Phase I/ Phase II

                          Sponsor : Integrative Therapeutics

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          Fraser Health

                          Country arrow
                          EPSC
                          Not Confirmed

                          Fraser Health

                          Country arrow
                          EPSC
                          Not Confirmed

                          Lead Product(s) : Tranexamic Acid,Inapplicable

                          Therapeutic Area : Urology

                          Study Phase : Phase I/ Phase II

                          Sponsor : BC Support Unit | Michael Smith Foundation for Health Research

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          September 18, 2020

                          Lead Product(s) : Tranexamic Acid,Inapplicable

                          Therapeutic Area : Urology

                          Highest Development Status : Phase I/ Phase II

                          Sponsor : BC Support Unit | Michael Smith Foundation for Health Research

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          EPSC
                          Not Confirmed
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          December 23, 2019

                          Lead Product(s) : SI-722,Inapplicable

                          Therapeutic Area : Urology

                          Highest Development Status : Phase I/ Phase II

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          06

                          EPSC
                          Not Confirmed
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          August 01, 2018

                          Lead Product(s) : Tamsulosin,Inapplicable

                          Therapeutic Area : Urology

                          Highest Development Status : Phase I/ Phase II

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          07

                          EPSC
                          Not Confirmed
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          March 29, 2018

                          Lead Product(s) : Rec 0/0438,Inapplicable

                          Therapeutic Area : Urology

                          Highest Development Status : Phase I/ Phase II

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          08

                          Ixaltis

                          Country arrow
                          EPSC
                          Not Confirmed

                          Ixaltis

                          Country arrow
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          January 12, 2018

                          Lead Product(s) : Litoxetine,Inapplicable

                          Therapeutic Area : Urology

                          Highest Development Status : Phase I/ Phase II

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          09

                          Li-Cor

                          Country arrow
                          EPSC
                          Not Confirmed

                          Li-Cor

                          Country arrow
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Other Small Molecule

                          Upfront Cash : Inapplicable

                          April 10, 2017

                          Lead Product(s) : Nerindocianine,Inapplicable

                          Therapeutic Area : Urology

                          Highest Development Status : Phase I/ Phase II

                          Sponsor : Inapplicable

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          10

                          Robert W. Alexander

                          Country arrow
                          EPSC
                          Not Confirmed

                          Robert W. Alexander

                          Country arrow
                          EPSC
                          Not Confirmed

                          Details : Undisclosed

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          November 10, 2016

                          Lead Product(s) : Microcannula Harvest Adipose,Sodium Chloride

                          Therapeutic Area : Urology

                          Highest Development Status : Phase I/ Phase II

                          Sponsor : Terry, Glenn C., M.D.

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank